1
SCHOLAR ROCK HLDG CORP
COM
SRRK
SRRK
9,250,005
$327.6m16.95%
16.95%
Unchanged Shares held: Q3 2024 11.3m, Q4 2024 9.3m, Q1 2025 9.3m, Q2 2025 9.3m
2
KYMERA THERAPEUTICS INC
COM
KYMR
KYMR
3,428,150
$149.6m7.74%
7.74%
Added Shares held: Q3 2024 3.0m, Q4 2024 3.0m, Q1 2025 3.2m, Q2 2025 3.4m
+187.8k
+187,837
5.8%
3
BEIGENE LTD
SPONSORED ADR
ONC
ONC
509,990
$123.5m6.39%
6.39%
Added Shares held: Q3 2024 563.3k, Q4 2024 653.7k, Q1 2025 498.7k, Q2 2025 510.0k
+11.3k
+11,301
2.3%
4
DISC MEDICINE INC
COM
IRON
IRON
1,099,401
$58.2m3.01%
3.01%
Added Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 1.1m, Q2 2025 1.1m
+27.5k
+27,536
2.6%
5
CRINETICS PHARMACEUTICALS IN
COM
CRNX
CRNX
1,688,611
$48.6m2.51%
2.51%
Unchanged Shares held: Q3 2024 1.3m, Q4 2024 1.6m, Q1 2025 1.7m, Q2 2025 1.7m
6
BICARA THERAPEUTICS INC
COM
BCAX
BCAX
5,216,969
$48.5m2.51%
2.51%
Added Shares held: Q3 2024 3.1m, Q4 2024 3.3m, Q1 2025 3.3m, Q2 2025 5.2m
+1.9m
+1,949,886
59.7%
7
DYNE THERAPEUTICS INC
COM
DYN
DYN
4,836,437
$46.0m2.38%
2.38%
Added Shares held: Q3 2024 1.1m, Q4 2024 1.3m, Q1 2025 2.7m, Q2 2025 4.8m
+2.1m
+2,118,450
77.9%
8
CENTESSA PHARMACEUTICALS PLC
SPONSORED ADS
SPONSORED ADS
3,460,029
$45.5m2.35%
2.35%
Added Shares held: Q3 2024 3.3m, Q4 2024 3.0m, Q1 2025 3.0m, Q2 2025 3.5m
+500.0k
+500,000
16.9%
9
MERUS N V
COM
MRUS
MRUS
853,467
$44.9m2.32%
2.32%
Reduced Shares held: Q3 2024 682.2k, Q4 2024 784.4k, Q1 2025 1.0m, Q2 2025 853.5k
-190.0k
-190,000
-18.2%
10
APELLIS PHARMACEUTICALS INC
COM
APLS
APLS
2,578,396
$44.6m2.31%
2.31%
Unchanged Shares held: Q3 2024 2.2m, Q4 2024 2.8m, Q1 2025 2.6m, Q2 2025 2.6m
11
ASCENDIS PHARMA A/S
SPONSORED ADR
SPONSORED ADR
245,943
$42.4m2.20%
2.20%
Reduced Shares held: Q3 2024 347.9k, Q4 2024 297.3k, Q1 2025 287.4k, Q2 2025 245.9k
-41.4k
-41,423
-14.4%
12
ARROWHEAD PHARMACEUTICALS IN
COM
ARWR
ARWR
2,669,880
$42.2m2.18%
2.18%
Unchanged Shares held: Q3 2024 2.5m, Q4 2024 2.9m, Q1 2025 2.7m, Q2 2025 2.7m
13
EDGEWISE THERAPEUTICS INC
COM
EWTX
EWTX
3,160,298
$41.4m2.14%
2.14%
Added Shares held: Q3 2024 404.1k, Q4 2024 734.3k, Q1 2025 1.7m, Q2 2025 3.2m
+1.5m
+1,463,854
86.3%
14
SOLENO THERAPEUTICS INC
COM
SLNO
SLNO
467,342
$39.2m2.03%
2.03%
Reduced Shares held: Q3 2024 0, Q4 2024 351.8k, Q1 2025 727.3k, Q2 2025 467.3k
-260.0k
-259,995
-35.8%
15
LEXICON PHARMACEUTICALS INC
COM NEW
LXRX
LXRX
38,918,903
$36.8m1.90%
1.90%
Unchanged Shares held: Q3 2024 38.9m, Q4 2024 38.9m, Q1 2025 38.9m, Q2 2025 38.9m
16
TABOOLA.COM LTD
ORD SHS
TBLA
TBLA
9,969,495
$36.5m1.89%
1.89%
Unchanged Shares held: Q3 2024 10.0m, Q4 2024 10.0m, Q1 2025 10.0m, Q2 2025 10.0m
17
SOLID BIOSCIENCES INC
COM NEW
SLDB
SLDB
7,415,905
$36.1m1.87%
1.87%
Unchanged Shares held: Q3 2024 2.7m, Q4 2024 3.7m, Q1 2025 7.4m, Q2 2025 7.4m
18
REVOLUTION MEDICINES INC
COM
RVMD
RVMD
938,755
$34.5m1.79%
1.79%
Added Shares held: Q3 2024 753.6k, Q4 2024 571.5k, Q1 2025 563.8k, Q2 2025 938.8k
+375.0k
+375,000
66.5%
19
AVIDITY BIOSCIENCES INC
COM
RNA
RNA
1,110,610
$31.5m1.63%
1.63%
Unchanged Shares held: Q3 2024 1.4m, Q4 2024 1.1m, Q1 2025 1.1m, Q2 2025 1.1m
20
RHYTHM PHARMACEUTICALS INC
COM
RYTM
RYTM
409,742
$25.9m1.34%
1.34%
Added Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 277.5k, Q2 2025 409.7k
+132.2k
+132,209
47.6%
21
APOGEE THERAPEUTICS INC
COM
COM
594,994
$25.8m1.34%
1.34%
Unchanged Shares held: Q3 2024 0, Q4 2024 747.3k, Q1 2025 595.0k, Q2 2025 595.0k
22
STOKE THERAPEUTICS INC
COM
STOK
STOK
2,247,347
$25.5m1.32%
1.32%
Unchanged Shares held: Q3 2024 0, Q4 2024 2.0m, Q1 2025 2.2m, Q2 2025 2.2m
23
TAYSHA GENE THERAPIES INC
COM SHS
TSHA
TSHA
11,014,737
$25.4m1.32%
1.32%
Added Shares held: Q3 2024 4.9m, Q4 2024 6.6m, Q1 2025 6.5m, Q2 2025 11.0m
+4.5m
+4,500,000
69.1%
24
XENON PHARMACEUTICALS INC
COM
XENE
XENE
812,761
$25.4m1.32%
1.32%
Added Shares held: Q3 2024 743.8k, Q4 2024 743.8k, Q1 2025 732.8k, Q2 2025 812.8k
+80.0k
+80,000
10.9%
25
WAVE LIFE SCIENCES LTD
SHS
96663EUR
96663EUR
3,696,322
$24.0m1.24%
1.24%
Unchanged Shares held: Q3 2024 5.7m, Q4 2024 3.8m, Q1 2025 3.7m, Q2 2025 3.7m
26
MOONLAKE IMMUNOTHERAPEUTICS
CLASS A ORD
MLTX
MLTX
508,267
$24.0m1.24%
1.24%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 508.3k
27
SEPTERNA INC
COM
SEPN
SEPN
2,202,514
$23.3m1.20%
1.20%
Unchanged Shares held: Q3 2024 0, Q4 2024 2.2m, Q1 2025 2.2m, Q2 2025 2.2m
28
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
NAMS
NAMS
1,194,240
$21.6m1.12%
1.12%
Reduced Shares held: Q3 2024 920.6k, Q4 2024 2.1m, Q1 2025 1.9m, Q2 2025 1.2m
-717.8k
-717,790
-37.5%
29
TREVI THERAPEUTICS INC
COM
TRVI
TRVI
3,938,793
$21.5m1.11%
1.11%
Added Shares held: Q3 2024 0, Q4 2024 2.9m, Q1 2025 2.9m, Q2 2025 3.9m
+1.1m
+1,075,000
37.5%
30
TANGO THERAPEUTICS INC
COM
TNGX
TNGX
3,364,814
$17.2m0.89%
0.89%
Added Shares held: Q3 2024 2.6m, Q4 2024 2.6m, Q1 2025 2.6m, Q2 2025 3.4m
+799.5k
+799,472
31.2%
31
AKERO THERAPEUTICS INC
COM
AKRO
AKRO
318,647
$17.0m0.88%
0.88%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 318.6k
32
SILENCE THERAPEUTICS PLC
ADS
SLN
SLN
2,911,438
$16.9m0.87%
0.87%
Added Shares held: Q3 2024 2.8m, Q4 2024 2.8m, Q1 2025 2.8m, Q2 2025 2.9m
+121.6k
+121,605
4.4%
33
ARRIVENT BIOPHARMA INC
COM
AVBP
AVBP
700,000
$15.2m0.79%
0.79%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 700.0k
34
BICYCLE THERAPEUTICS PLC
SPONSORED ADS
BCYC
BCYC
2,012,752
$14.0m0.72%
0.72%
Added Shares held: Q3 2024 0, Q4 2024 1.8m, Q1 2025 1.8m, Q2 2025 2.0m
+200.0k
+200,000
11.0%
35
ARCUS BIOSCIENCES INC
COM
RCUS
RCUS
1,612,077
$13.1m0.68%
0.68%
Unchanged Shares held: Q3 2024 1.6m, Q4 2024 1.6m, Q1 2025 1.6m, Q2 2025 1.6m
36
IHS HOLDING LIMITED
ORD SHS
IHS
IHS
2,357,520
$13.1m0.68%
0.68%
Unchanged Shares held: Q3 2024 2.4m, Q4 2024 2.4m, Q1 2025 2.4m, Q2 2025 2.4m
37
AMAZON COM INC
COM
AMZN
AMZN
56,500
$12.4m0.64%
0.64%
Unchanged Shares held: Q3 2024 34.8k, Q4 2024 36.5k, Q1 2025 56.5k, Q2 2025 56.5k
38
DENALI THERAPEUTICS INC
COM
DNLI
DNLI
821,513
$11.5m0.59%
0.59%
Unchanged Shares held: Q3 2024 834.0k, Q4 2024 834.0k, Q1 2025 821.5k, Q2 2025 821.5k
39
ERASCA INC
COM
ERAS
ERAS
8,757,249
$11.1m0.58%
0.58%
Unchanged Shares held: Q3 2024 8.9m, Q4 2024 8.9m, Q1 2025 8.8m, Q2 2025 8.8m
40
ORIC PHARMACEUTICALS INC
COM
ORIC
ORIC
1,007,575
$10.2m0.53%
0.53%
Unchanged Shares held: Q3 2024 1.0m, Q4 2024 1.0m, Q1 2025 1.0m, Q2 2025 1.0m
41
REMITLY GLOBAL INC
COM
RELY
RELY
515,449
$9.7m0.50%
0.50%
Added Shares held: Q3 2024 25.0k, Q4 2024 490.4k, Q1 2025 490.4k, Q2 2025 515.4k
+25.0k
+25,000
5.1%
42
VAXCYTE INC
COM
PCVX
PCVX
295,543
$9.6m0.50%
0.50%
Unchanged Shares held: Q3 2024 300.0k, Q4 2024 300.0k, Q1 2025 295.5k, Q2 2025 295.5k
43
CROWDSTRIKE HLDGS INC
CL A
CRWD
CRWD
18,500
$9.4m0.49%
0.49%
Reduced Shares held: Q3 2024 25.0k, Q4 2024 24.0k, Q1 2025 25.0k, Q2 2025 18.5k
-6.5k
-6,500
-26.0%
44
CULLINAN THERAPEUTICS INC
COM
CGEM
CGEM
1,193,410
$9.0m0.47%
0.47%
Unchanged Shares held: Q3 2024 1.2m, Q4 2024 1.2m, Q1 2025 1.2m, Q2 2025 1.2m
45
ALPHABET INC
CAP STK CL A
GOOGL
GOOGL
50,703
$8.9m0.46%
0.46%
Unchanged Shares held: Q3 2024 11.0k, Q4 2024 7.0k, Q1 2025 50.7k, Q2 2025 50.7k
46
UPSTREAM BIO INC
COM
UPB
UPB
788,450
$8.7m0.45%
0.45%
Unchanged Shares held: Q3 2024 0, Q4 2024 800.0k, Q1 2025 788.5k, Q2 2025 788.5k
47
SEER INC
COM CL A
SEER
SEER
4,000,000
$8.6m0.44%
0.44%
Unchanged Shares held: Q3 2024 4.0m, Q4 2024 4.0m, Q1 2025 4.0m, Q2 2025 4.0m
48
MICROSOFT CORP
COM
MSFT
MSFT
16,150
$8.0m0.42%
0.42%
Reduced Shares held: Q3 2024 22.0k, Q4 2024 23.0k, Q1 2025 28.5k, Q2 2025 16.1k
-12.3k
-12,350
-43.3%
49
NVIDIA CORPORATION
COM
NVDA
NVDA
49,985
$7.9m0.41%
0.41%
Added Shares held: Q3 2024 48.9k, Q4 2024 48.9k, Q1 2025 44.4k, Q2 2025 50.0k
+5.6k
+5,553
12.5%
50
IONQ INC
COM
IONQ
IONQ
170,000
$7.3m0.38%
0.38%
Unchanged Shares held: Q3 2024 500.0k, Q4 2024 170.0k, Q1 2025 170.0k, Q2 2025 170.0k
51
TAIWAN SEMICONDUCTOR MFG LTD
SPONSORED ADS
TSM
TSM
30,500
$6.9m0.36%
0.36%
Added Shares held: Q3 2024 25.0k, Q4 2024 15.0k, Q1 2025 28.5k, Q2 2025 30.5k
+2.0k
+2,000
7.0%
52
GOSSAMER BIO INC
COM
GOSS
GOSS
5,208,968
$6.4m0.33%
0.33%
Unchanged Shares held: Q3 2024 13.3m, Q4 2024 5.2m, Q1 2025 5.2m, Q2 2025 5.2m
53
SALESFORCE INC
COM
CRM
CRM
22,600
$6.2m0.32%
0.32%
Added Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 14.6k, Q2 2025 22.6k
+8.0k
+8,000
54.8%
54
COGENT BIOSCIENCES INC
COM
COGT
COGT
854,379
$6.1m0.32%
0.32%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 854.4k
55
CARTESIAN THERAPEUTICS INC
COM NEW
RNAC
RNAC
563,272
$5.9m0.30%
0.30%
Unchanged Shares held: Q3 2024 572.2k, Q4 2024 572.2k, Q1 2025 563.3k, Q2 2025 563.3k
56
VERA THERAPEUTICS INC
CL A
VERA
VERA
247,216
$5.8m0.30%
0.30%
Reduced Shares held: Q3 2024 837.9k, Q4 2024 758.5k, Q1 2025 747.2k, Q2 2025 247.2k
-500.0k
-500,000
-66.9%
57
ADOBE INC
COM
ADBE
ADBE
15,051
$5.8m0.30%
0.30%
Reduced Shares held: Q3 2024 1.0k, Q4 2024 8.8k, Q1 2025 19.3k, Q2 2025 15.1k
-4.2k
-4,247
-22.0%
58
SIONNA THERAPEUTICS INC
COM
SION
SION
325,000
$5.6m0.29%
0.29%
Unchanged Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 325.0k, Q2 2025 325.0k
59
PDD HOLDINGS INC
SPONSORED ADS
PDD
PDD
52,901
$5.5m0.29%
0.29%
Unchanged Shares held: Q3 2024 40.4k, Q4 2024 52.9k, Q1 2025 52.9k, Q2 2025 52.9k
60
SAGIMET BIOSCIENCES INC
COM SER A
SGMT
SGMT
724,771
$5.5m0.29%
0.29%
Unchanged Shares held: Q3 2024 724.8k, Q4 2024 724.8k, Q1 2025 724.8k, Q2 2025 724.8k
61
SPYRE THERAPEUTICS INC
COM NEW
SYRE
SYRE
368,598
$5.5m0.29%
0.29%
Unchanged Shares held: Q3 2024 0, Q4 2024 374.0k, Q1 2025 368.6k, Q2 2025 368.6k
62
PACIRA BIOSCIENCES INC
COM
PCRX
PCRX
225,000
$5.4m0.28%
0.28%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 225.0k
63
SERVICENOW INC
COM
NOW
NOW
5,126
$5.3m0.27%
0.27%
Reduced Shares held: Q3 2024 7.5k, Q4 2024 5.6k, Q1 2025 9.1k, Q2 2025 5.1k
-4.0k
-4,000
-43.8%
64
KORRO BIO INC
COM
KRRO
KRRO
418,833
$5.2m0.27%
0.27%
Unchanged Shares held: Q3 2024 418.8k, Q4 2024 418.8k, Q1 2025 418.8k, Q2 2025 418.8k
65
DATADOG INC
CL A COM
DDOG
DDOG
38,425
$5.2m0.27%
0.27%
Reduced Shares held: Q3 2024 32.9k, Q4 2024 30.4k, Q1 2025 47.4k, Q2 2025 38.4k
-9.0k
-9,000
-19.0%
66
AGENUS INC
COM NEW
AGEN
AGEN
1,064,250
$4.9m0.25%
0.25%
Added Shares held: Q3 2024 775.0k, Q4 2024 0, Q1 2025 500.0k, Q2 2025 1.1m
+564.2k
+564,250
112.8%
67
JFROG LTD
ORD SHS
FROG
FROG
107,116
$4.7m0.24%
0.24%
Reduced Shares held: Q3 2024 61.0k, Q4 2024 120.1k, Q1 2025 131.6k, Q2 2025 107.1k
-24.5k
-24,500
-18.6%
68
RAPPORT THERAPEUTICS INC
COM
RAPP
RAPP
378,469
$4.3m0.22%
0.22%
Unchanged Shares held: Q3 2024 384.2k, Q4 2024 384.2k, Q1 2025 378.5k, Q2 2025 378.5k
69
INSTIL BIO INC
COM NEW
TIL
TIL
203,933
$4.2m0.22%
0.22%
Unchanged Shares held: Q3 2024 192.4k, Q4 2024 192.4k, Q1 2025 203.9k, Q2 2025 203.9k
70
DYNATRACE INC
COM NEW
DT
DT
75,229
$4.2m0.21%
0.21%
Reduced Shares held: Q3 2024 82.7k, Q4 2024 82.7k, Q1 2025 87.7k, Q2 2025 75.2k
-12.5k
-12,500
-14.2%
71
AADI BIOSCIENCE INC
COM
WHWK
WHWK
2,082,000
$3.9m0.20%
0.20%
Unchanged Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 2.1m, Q2 2025 2.1m
72
NEW ORIENTAL ED & TECHNOLOGY
SPON ADR
EDU
EDU
72,000
$3.9m0.20%
0.20%
Reduced Shares held: Q3 2024 38.5k, Q4 2024 68.5k, Q1 2025 79.5k, Q2 2025 72.0k
-7.5k
-7,500
-9.4%
73
IGM BIOSCIENCES INC
COM
IGMS
IGMS
3,255,826
$3.6m0.19%
0.19%
Unchanged Shares held: Q3 2024 3.3m, Q4 2024 3.3m, Q1 2025 3.3m, Q2 2025 3.3m
74
FOGHORN THERAPEUTICS INC
COM
FHTX
FHTX
720,720
$3.4m0.18%
0.18%
Unchanged Shares held: Q3 2024 720.7k, Q4 2024 720.7k, Q1 2025 720.7k, Q2 2025 720.7k
75
VIGIL NEUROSCIENCE INC
COM
VIGL
VIGL
411,191
$3.3m0.17%
0.17%
Reduced Shares held: Q3 2024 2.0m, Q4 2024 2.0m, Q1 2025 2.0m, Q2 2025 411.2k
-1.6m
-1,555,873
-79.1%
76
NEUMORA THERAPEUTICS INC.
COM
NMRA
NMRA
4,358,283
$3.2m0.17%
0.17%
Unchanged Shares held: Q3 2024 2.6m, Q4 2024 4.4m, Q1 2025 4.4m, Q2 2025 4.4m
77
PROQR THRAPEUTICS N V
SHS EURO
PRQR
PRQR
1,552,183
$3.2m0.16%
0.16%
Unchanged Shares held: Q3 2024 0, Q4 2024 1.6m, Q1 2025 1.6m, Q2 2025 1.6m
78
NEBIUS GROUP N.V.
SHS CLASS A
NBIS
NBIS
51,000
$2.8m0.15%
0.15%
Reduced Shares held: Q3 2024 0, Q4 2024 120.0k, Q1 2025 140.0k, Q2 2025 51.0k
-89.0k
-89,000
-63.6%
79
BLACK DIAMOND THERAPEUTICS I
COM
BDTX
BDTX
1,046,517
$2.6m0.13%
0.13%
Unchanged Shares held: Q3 2024 1.0m, Q4 2024 1.0m, Q1 2025 1.0m, Q2 2025 1.0m
80
LEXEO THERAPEUTICS INC
COM
LXEO
LXEO
603,435
$2.4m0.13%
0.13%
Unchanged Shares held: Q3 2024 603.4k, Q4 2024 603.4k, Q1 2025 603.4k, Q2 2025 603.4k
81
PALO ALTO NETWORKS INC
COM
PANW
PANW
11,500
$2.4m0.12%
0.12%
Unchanged Shares held: Q3 2024 9.0k, Q4 2024 6.0k, Q1 2025 11.5k, Q2 2025 11.5k
82
QUALCOMM INC
COM
QCOM
QCOM
14,000
$2.2m0.12%
0.12%
Unchanged Shares held: Q3 2024 15.0k, Q4 2024 15.0k, Q1 2025 14.0k, Q2 2025 14.0k
83
WORKIVA INC
COM CL A
WK
WK
28,000
$1.9m0.10%
0.10%
Added Shares held: Q3 2024 0, Q4 2024 10.0k, Q1 2025 17.5k, Q2 2025 28.0k
+10.5k
+10,500
60.0%
84
ELEDON PHARMACEUTICALS INC
COM
ELDN
ELDN
690,170
$1.9m0.10%
0.10%
Unchanged Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 690.2k, Q2 2025 690.2k
85
KE HLDGS INC
SPONSORED ADS
BEKE
BEKE
105,000
$1.9m0.10%
0.10%
Unchanged Shares held: Q3 2024 100.0k, Q4 2024 60.0k, Q1 2025 105.0k, Q2 2025 105.0k
86
HUBSPOT INC
COM
HUBS
HUBS
3,000
$1.7m0.09%
0.09%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 3.0k
87
UNITEDHEALTH GROUP INC
COM
UNH
UNH
5,076
$1.6m0.08%
0.08%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 5.1k
88
BIOAGE LABS INC
COM
BIOA
BIOA
382,406
$1.6m0.08%
0.08%
Unchanged Shares held: Q3 2024 300.0k, Q4 2024 388.0k, Q1 2025 382.4k, Q2 2025 382.4k
89
GITLAB INC
CLASS A COM
GTLB
GTLB
35,000
$1.6m0.08%
0.08%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 35.0k
90
TOURMALINE BIO INC
COM
TRML
TRML
91,426
$1.5m0.08%
0.08%
Unchanged Shares held: Q3 2024 91.4k, Q4 2024 91.4k, Q1 2025 91.4k, Q2 2025 91.4k
91
ROCKET PHARMACEUTICALS INC
COM
RCKT
RCKT
591,263
$1.4m0.07%
0.07%
Unchanged Shares held: Q3 2024 0, Q4 2024 600.0k, Q1 2025 591.3k, Q2 2025 591.3k
92
TESLA INC
COM
TSLA
TSLA
4,000
$1.3m0.07%
0.07%
Reduced Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 9.0k, Q2 2025 4.0k
-5.0k
-5,000
-55.6%
93
BIRKENSTOCK HOLDING PLC
COM SHS
BIRK
BIRK
25,000
$1.2m0.06%
0.06%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 25.0k
94
SAILPOINT INC
COM
SAIL
SAIL
50,000
$1.1m0.06%
0.06%
Reduced Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 95.0k, Q2 2025 50.0k
-45.0k
-45,000
-47.4%
95
SEMRUSH HLDGS INC
CL A COM
SEMR
SEMR
125,000
$1.1m0.06%
0.06%
Unchanged Shares held: Q3 2024 0, Q4 2024 35.0k, Q1 2025 125.0k, Q2 2025 125.0k
96
PRIMO BRANDS CORPORATION
CLASS A COM SHS
PRMB
PRMB
37,500
$1.1m0.06%
0.06%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 37.5k
97
CELLEBRITE DI LTD
ORDINARY SHARES
CLBT
CLBT
60,000
$960.0k0.05%
0.05%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 60.0k
98
GENERATION BIO CO
COM
COM
2,968,925
$950.4k0.05%
0.05%
Unchanged Shares held: Q3 2024 3.0m, Q4 2024 3.0m, Q1 2025 3.0m, Q2 2025 3.0m
99
KALARIS THERAPEUTICS INC
COM
KLRS
KLRS
282,586
$754.5k0.04%
0.04%
Unchanged Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 282.6k, Q2 2025 282.6k
100
HOOKIPA PHARMA INC
COM NEW
COM NEW
566,640
$711.1k0.04%
0.04%
Unchanged Shares held: Q3 2024 566.6k, Q4 2024 566.6k, Q1 2025 566.6k, Q2 2025 566.6k